We developed the NeoDoppler system because there is currently no direct continuous measurement of brain blood flow available, despite an undeniable clinical need world wide.
Cimon Medical exists to innovate life saving solutions. We do this by developing and manufacturing Doppler ultrasound technology for health care facilities.
NeoDoppler can play a decisive role in the assessment of cerebral perfusion.
Monitoring the circulation of the
newborn is important but difficult,
especially during incubator transport.
NeoDoppler has the potential to
overcome these challenges, and is
one of the most promising novel
medical device in this field of
medicine. It is well tolerated, noninvasive
and easy-to-use. We believe
that this technology is an important
step forward for this vulnerable group
of patients.